Breaking News Instant updates and real-time market news.

ALXN

Alexion

$99.22

-1.38 (-1.37%)

06:35
10/23/19
10/23
06:35
10/23/19
06:35

Alexion CEO says 'delivered another record performance' in Q3

"With consistent and strong execution, we have delivered another record performance in the third quarter, building on our momentum from the first half of 2019. Our teams continued to demonstrate launch excellence across the globe, with very rapid starts to the German and Japanese ULTOMIRIS PNH launches, where conversion is progressing ahead of the best-in-class U.S. launch at the same time points, as well as a strong start to the SOLIRIS NMOSD launch in the U.S.," said Ludwig Hantson, Ph.D., CEO of Alexion. "We also continued to expand our portfolio with two additional approvals - ULTOMIRIS for atypical HUS in the U.S. and SOLIRIS for NMOSD in the EU - and three new business development transactions that further diversify our pipeline, including an agreement to acquire Achillion. By continuing to deliver on the ambitious transformation plan we laid out two-and-a-half years ago, we have successfully established a strong foundation for the future and look forward to building on this progress as we advance our mission of delivering life-changing therapies to people with rare diseases."

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

ALXN Alexion
$99.22

-1.38 (-1.37%)

10/04/19
GUGG
10/04/19
NO CHANGE
GUGG
Guggenheim positively biased on Biotech heading into earnings
Guggenheim analysts Whitney Ijem, Etzer Darout, Yatin Suneja and Michael Schmidt offered a preview for their joint Biotech coverage ahead of the group's earnings reporting season. Biotech stocks continued their downward trend in the quarter amid negative market sentiment and the analysts think the bar for companies to raise 2019 guidance again may be a bit higher following increases in FY19 consensus estimates on the heels of strong Q2 earnings results. However, they are postively biased on the group and have confidence in FY19 guidance and estimates, the analysts said. They see Alexion (ALXN), Biogen (BIIB), Genmab (GMAB), GW Pharmaceuticals (GWPH), Incyte (INCY), Neurocrine (NBIX), Regeneron (REGN) and Seattle Genetics (SGEN) as well positioned relative to expectations, Ijem, Darout, Suneja and Schmidt tell investors.
10/16/19
PIPR
10/16/19
NO CHANGE
Target $180
PIPR
Overweight
Piper likes Alexion acquisition of Achillion, remains buyer of shares
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on Alexion Pharmaceuticals (ALXN) with a $180 price target after this morning's announced acquisition of Achillion Pharmaceuticals (ACHN). The deal brings in danicopan, an oral Factor D inhibitor, as combination therapy with Soliris for the treatment of paroxysmal nocturnal hemoglobinuria and monotherapy for C3 glomerulopathy, and ACH-5228, a second generation oral Factor D inhibitor, expected to enter the clinic early next year, Raymond tells investors in a research note. The analyst likes the deal. Achillion has already shown proof of concept in PNH and strategically the company adds to the diversification of Alexion's pipeline, says Raymond. The analyst remains a buyer of Alexion shares.
10/17/19
BOFA
10/17/19
INITIATION
Target $130
BOFA
Buy
Alexion reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Geoff Meacham reinstated coverage of Alexion Pharmaceuticals with a Buy rating and $130 price target. "Noise" around complement competition has overshadowed Alexion's "strong" fundamentals, driven by its Soliris/Ultomiris franchise, Meacham tells investors in a research note. The analyst likes the stock's risk/reward profile given the company's "differentiated" growth and "discounted" valuation.
10/18/19
LEER
10/18/19
DOWNGRADE
Target $6.3
LEER
Market Perform
Achillion acquisition by Alexion 'makes logical sense,' says SVB Leerink
SVB Leerink analyst Joseph Schwartz downgraded Achillion (ACHN) to Market Perform from Outperform with a price target of $6.30, up from $5. In a research note to investors, Schwartz says he thinks Alexion's (ALXN) proposed acquisition of Achillion makes logical sense as it brings highly complementary assets that can deliver a broader market opportunity together at a time "when the complement space could get more competitive." The analyst thinks the deal will close without any competing bids.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
11/15/19
11/15
11:17
11/15/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
11/15/19
11/15
11:16
11/15/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
11/15/19
11/15
11:15
11/15/19
11:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

MNTA

Momenta

$15.82

-0.21 (-1.31%)

11:14
11/15/19
11/15
11:14
11/15/19
11:14
Hot Stocks
Momenta confirms first patient in the Unity study has delivered a full-term baby »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 16

    Dec

ONTO

Onto Innovation

$35.31

0.97 (2.82%)

11:10
11/15/19
11/15
11:10
11/15/19
11:10
Conference/Events
Onto Innovation management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

  • 21

    Nov

LOGM

LogMeln

$73.98

0.77 (1.05%)

11:09
11/15/19
11/15
11:09
11/15/19
11:09
Periodicals
LogMeln in 'deep talks' to sell itself, blog report claims »

LogMeIn is "in deep…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LK

Luckin Coffee

$23.90

2.37 (11.01%)

11:05
11/15/19
11/15
11:05
11/15/19
11:05
Options
Luckin Coffee call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

BABA

Alibaba

$185.03

2.34 (1.28%)

11:00
11/15/19
11/15
11:00
11/15/19
11:00
Periodicals
Alibaba order books for Hong Kong listing covered 'multiple times,' Reuters says »

Alibaba's $13.4B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

11:00
11/15/19
11/15
11:00
11/15/19
11:00
General news
Today's U.S. reports »

Today's U.S. reports…

TORC

resTORbio

$1.35

-6.58 (-82.98%)

10:51
11/15/19
11/15
10:51
11/15/19
10:51
Downgrade
resTORbio rating change  »

resTORbio downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRSN

VeriSign

$186.74

-0.36 (-0.19%)

10:50
11/15/19
11/15
10:50
11/15/19
10:50
Options
Delta neutral call buyers in VeriSign December »

Delta neutral call buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAA

Under Armour

$17.47

0.34 (1.98%)

, UA

Under Armour

$15.76

0.2 (1.29%)

10:47
11/15/19
11/15
10:47
11/15/19
10:47
Hot Stocks
Under Armour says 'always in compliance' with GAAP amid scrutiny »

Under Armour said earlier…

UAA

Under Armour

$17.47

0.34 (1.98%)

UA

Under Armour

$15.76

0.2 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$204.28

-5.605 (-2.67%)

10:40
11/15/19
11/15
10:40
11/15/19
10:40
Options
Nvidia options volume 7x normal as shares whip post earnings »

Nvidia options volume 7x…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 06

    Jan

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

10:30
11/15/19
11/15
10:30
11/15/19
10:30
On The Fly
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

CS

Credit Suisse

$12.98

0.135 (1.05%)

NVDA

Nvidia

$202.92

-6.96 (-3.32%)

OSTK

Overstock.com

$8.30

0.12 (1.47%)

AMD

AMD

$39.05

0.69 (1.80%)

DPW

DPW Holdings

$1.16

-0.06 (-4.92%)

KODK

Kodak

$2.35

-0.02 (-0.84%)

RIOT

Riot Blockchain

$1.53

-0.05 (-3.16%)

TEUM

Pareteum

$0.39

-0.006 (-1.50%)

SRAX

Social Reality

$1.56

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 09

    Dec

  • 06

    Jan

PPL

PPL Corp.

$33.72

0.1 (0.30%)

10:30
11/15/19
11/15
10:30
11/15/19
10:30
Options
Size call spread in PPL Corp reloads short calls »

Size call spread in PPL…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$292.26

2.58 (0.89%)

, HPQ

HP Inc.

$20.13

0.01 (0.05%)

10:29
11/15/19
11/15
10:29
11/15/19
10:29
Recommendations
Netflix, HP Inc., Aramark analyst commentary  »

Gordon Haskett says…

NFLX

Netflix

$292.26

2.58 (0.89%)

HPQ

HP Inc.

$20.13

0.01 (0.05%)

ARMK

Aramark

$43.38

0.08 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 21

    Nov

  • 26

    Nov

  • 09

    Dec

  • 10

    Dec

10:25
11/15/19
11/15
10:25
11/15/19
10:25
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

DTIL

Precision BioSciences

$11.35

-0.45 (-3.81%)

10:25
11/15/19
11/15
10:25
11/15/19
10:25
Conference/Events
Precision BioSciences participates in a conference call with BTIG »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 07

    Dec

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

10:20
11/15/19
11/15
10:20
11/15/19
10:20
Options
Put sale in VIX appears to exit two-week position for 64% gain »

Put sale in VIX appears…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
11/15/19
11/15
10:20
11/15/19
10:20
General news
The September business inventory report undershot estimates »

The September business…

AMRN

Amarin

$22.68

1.19 (5.54%)

10:19
11/15/19
11/15
10:19
11/15/19
10:19
On The Fly
One analyst thinks Amarin could rise toward $50 after positive FDA panel vote »

Shares of Amarin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/15/19
11/15
10:17
11/15/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAYS

Paysign

$10.74

-0.53 (-4.70%)

, WAB

Wabtec

$79.36

0.82 (1.04%)

10:16
11/15/19
11/15
10:16
11/15/19
10:16
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

PAYS

Paysign

$10.74

-0.53 (-4.70%)

WAB

Wabtec

$79.36

0.82 (1.04%)

AWK

American Water

$117.25

-0.65 (-0.55%)

RIGL

Rigel Pharmaceuticals

$2.32

0.035 (1.53%)

LPSN

LivePerson

$37.54

1.12 (3.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 25

    Nov

  • 26

    Nov

  • 07

    Dec

  • 10

    Dec

MITK

Mitek Systems

$7.35

-0.35 (-4.55%)

, AGCO

Agco

$80.01

-0.11 (-0.14%)

10:16
11/15/19
11/15
10:16
11/15/19
10:16
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

MITK

Mitek Systems

$7.35

-0.35 (-4.55%)

AGCO

Agco

$80.01

-0.11 (-0.14%)

GPOR

Gulfport Energy

$2.84

-0.26 (-8.39%)

CNP

CenterPoint Energy

$25.31

-1.37 (-5.13%)

NVDA

Nvidia

$204.18

-5.7 (-2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 13

    Dec

  • 06

    Jan

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
11/15/19
11/15
10:16
11/15/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.